Literature DB >> 24154658

[Significance of sonographically guided percutaneous needle biopsy in the diagnostics of soft tissue tumors].

A K Gillenberg1, F Länger, U Brunnemer, V Grünwald, C Krettek, T Gösling.   

Abstract

BACKGROUND: The role of percutaneous needle biopsy in the diagnostics of soft tissue tumors is controversially discussed. The specificity of this method has been examined in this study based on the collective of patients treated in our university hospital. Secondly, the influence of the specialization of the treating surgeon has been evaluated. PATIENTS AND METHODS: This study included 96 patients who underwent percutaneous needle biopsy and, if necessary, surgical resection. The specificity, logistic requirements and possible complications of percutaneous biopsy were evaluated. Special attention was paid to the influence of specialization of the treating surgical team on the specificity of the method.
RESULTS: The results of the biopsy were able to define the entity of the lesion correctly in 69.7 %, the dignity in 75.0 % and the grading in 72.0 % of the cases. In the group treated by a specialized team, the specificity of the method was 84.6 % concerning the entity of the lesion, 84.6 % concerning the dignity and 80 % concerning the grading. With regard to the entity the specificity was significantly increased (p < 0.05).
CONCLUSION: The findings show that percutaneous needle biopsy represents a logistically simple and efficient diagnostic method for soft tissue tumors which is rarely associated with complications. Subsequent treatment should be performed in a specialized centre.

Entities:  

Mesh:

Year:  2013        PMID: 24154658     DOI: 10.1007/s00132-013-2135-8

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  31 in total

Review 1.  The diagnosis and treatment of soft tissue sarcomas of the limbs.

Authors:  Holger Bannasch; Steffen U Eisenhardt; Anca-Ligia Grosu; Jürgen Heinz; Arash Momeni; G Björn Stark
Journal:  Dtsch Arztebl Int       Date:  2011-01-21       Impact factor: 5.594

Review 2.  Needle tract recurrences after closed biopsy for sarcoma: three cases and review of the literature.

Authors:  H S Schwartz; D M Spengler
Journal:  Ann Surg Oncol       Date:  1997 Apr-May       Impact factor: 5.344

Review 3.  [Soft tissue sarcoma: prognostic factors and multimodal treatment].

Authors:  A Hoos; J J Lewis; M F Brennan
Journal:  Chirurg       Date:  2000-07       Impact factor: 0.955

4.  Diagnostic sensitivity of ultrasound-guided needle biopsy in soft tissue masses about superficial bone lesions.

Authors:  K M Yeow; C F Tan; J S Chen; C Hsueh
Journal:  J Ultrasound Med       Date:  2000-12       Impact factor: 2.153

Review 5.  Grading of soft tissue sarcomas: review and update.

Authors:  Jean-Michel Coindre
Journal:  Arch Pathol Lab Med       Date:  2006-10       Impact factor: 5.534

Review 6.  Soft tissue tumors: new perspectives on classification and diagnosis.

Authors:  Kathrin Katenkamp; Detlef Katenkamp
Journal:  Dtsch Arztebl Int       Date:  2009-09-25       Impact factor: 5.594

7.  A prospective study of the value of core needle biopsy and fine needle aspiration in the diagnosis of soft tissue masses.

Authors:  R J Barth; M J Merino; D Solomon; J C Yang; A R Baker
Journal:  Surgery       Date:  1992-09       Impact factor: 3.982

8.  Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas.

Authors:  Thomas F DeLaney; Ira J Spiro; Herman D Suit; Mark C Gebhardt; Francis J Hornicek; Henry J Mankin; Andrew L Rosenberg; Daniel I Rosenthal; Fariba Miryousefi; Marcus Ancukiewicz; David C Harmon
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-07-15       Impact factor: 7.038

9.  Management of soft tissue sarcoma.

Authors:  M E Pitcher; S Fish; J M Thomas
Journal:  Br J Surg       Date:  1994-08       Impact factor: 6.939

10.  Evaluation of core needle biopsy as a substitute to open biopsy in the diagnosis of soft-tissue masses.

Authors:  I Ray-Coquard; D Ranchère-Vince; P Thiesse; H Ghesquières; P Biron; M-P Sunyach; M Rivoire; L Lancry; P Méeus; C Sebban; J-Y Blay
Journal:  Eur J Cancer       Date:  2003-09       Impact factor: 9.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.